Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurobiological Basis of Response to Vyvanse in Adults With ADHD
NCT01924429Phase 4Completed
- Start
- Mar 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lisdexamfetamine in attention deficit hyperactivity disorder (ADHD). Started Mar 2013; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01924429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01924429.